Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects
Crossref DOI link: https://doi.org/10.1007/s40261-015-0357-8
Published Online: 2015-11-23
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Parasrampuria, Dolly A.
Weilert, Doris
Maa, Jen-Fue
Dishy, Victor
Kochan, Jarema
Shi, Minggao
Brown, Karen S.
Funding for this research was provided by:
Daiichi Sankyo, Inc
License valid from 2015-11-23